
|Videos|January 19, 2015
Dr. Laura Dawson on HCC Challenges
Author(s)Laura Dawson, MD
Laura Dawson, MD, Princess Margaret Hospital, University of Toronto, talks about the challenges in treating hepatocellular carcinoma (HCC).
Advertisement
Laura Dawson, MD, Princess Margaret Hospital, University of Toronto, talks about the challenges in treating hepatocellular carcinoma (HCC).
Large portions of patients with HCC present with locally advanced disease and don’t get any chance for treatment because disease is too far progressed. This is mainly due to a lack of screening for the disease, says Dawson.
Research focus should be on detection methods for early stage HCC. Those at high risk, including those with hepatitis B or C or cirrhosis, should be screened regularly for the disease.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5




































